Aarti Drugs has announced the relaunch of the ‘Saksham Niveshak’ campaign, a 100-day initiative aimed at reaching out to shareholders with unpaid or unclaimed dividends. The campaign, which runs from April 1, 2026, to July 9, 2026, is in response to a request from the Investor Education and Protection Fund Authority (IEPFA) under the Ministry of Corporate Affairs (MCA).
The primary goal of the campaign is to encourage shareholders to update their KYC details and claim any unpaid dividends before they are transferred to the Investor Education and Protection Fund (IEPF). Shareholders are urged to update their PAN, nomination details, contact information, bank account details, and specimen signature with the Registrar & Share Transfer Agent, MUFG Intime India Private Limited, or their Depository Participant.
To facilitate the process, shareholders are required to submit various forms, including Form ISR-1 for KYC updates, Form ISR-2 for signature attestation and bank details, Form SH-13 for adding a nominee, and Form ISR-3 for opting out of nomination. These forms can be submitted either by post or email, or uploaded online through MUFG’s portal.
Aarti Drugs has also made available the details of unclaimed dividends for the past seven years on its website. Shareholders are advised to claim such dividends to prevent their transfer to the IEPF authority. The company has committed to sending letters or emails to shareholders with details of unpaid dividends and the claiming process.
In cases where dividends remain unclaimed for seven consecutive years, the corresponding equity shares will be transferred to the IEPF authority as per MCA notifications. Shareholders with dividends or shares already transferred to the IEPF can reclaim them by submitting Form IEPF-5 online and sending physical documents to the company or RTA.
For further assistance regarding the ‘Saksham Niveshak’ campaign, shareholders can contact Aarti Drugs or MUFG Intime India Private Limited through the provided contact details.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).